Search Results - "Casas, Magdalena"
-
1
Abnormal eye movements increase as motor disabilities and cognitive impairments become more evident in Multiple Sclerosis: A novel eye-tracking study
Published in Multiple sclerosis journal - experimental, translational and clinical (01-04-2024)“…Background Eye movements can reflect brain alterations and inform on the presence of motor disabilities and cognitive impairments in people with multiple…”
Get full text
Journal Article -
2
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies
Published in Multiple sclerosis journal - experimental, translational and clinical (01-01-2023)“…Background We aimed to determine the proportion of highly active multiple sclerosis patients under high-efficacy therapies (HETs) achieve no evidence of…”
Get full text
Journal Article -
3
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina
Published in Clinical neuropharmacology (01-07-2024)“…The aim was to evaluate patient profiles, effectiveness and safety of cladribine (CLAD) in patients with relapsing-remitting multiple sclerosis in Argentina…”
Get full text
Journal Article -
4
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina
Published in Clinical neuropharmacology (01-07-2024)“…The aim was to evaluate patient profiles, effectiveness and safety of cladribine (CLAD) in patients with relapsing-remitting multiple sclerosis in Argentina…”
Get full text
Journal Article -
5
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness
Published in Neurological sciences (01-12-2024)“…Introduction Cladribine was approved for Multiple Sclerosis (MS) in our country in 2018. A previous study by our group showed that its use among high efficacy…”
Get full text
Journal Article -
6
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM
Published in Multiple sclerosis and related disorders (01-06-2021)“…There is no data regarding COVID-19 in Multiple Sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients in Latin America. The objective of…”
Get full text
Journal Article -
7
Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis
Published in Multiple sclerosis and related disorders (01-01-2022)“…Peripheral inflammation can exacerbate pre-existing lesions in the Central Nervous System (CNS) in the context of neurodegenerative diseases, including…”
Get full text
Journal Article -
8
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina
Published in Multiple sclerosis and related disorders (01-11-2023)“…•There are limited data regarding the use of high-efficacy treatments in LATAM.•One third of those patients received HETs as the first treatment, in second…”
Get full text
Journal Article -
9
Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America
Published in Multiple sclerosis and related disorders (01-04-2023)“…•NMOSD was associated with poorer clinical outcomes than MOGAD.•Older age was a predictor of severe visual disability (OR=1,03, p = 0.03).•Older age (OR=1,04,…”
Get full text
Journal Article -
10
Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from Argentina
Published in Multiple sclerosis and related disorders (01-02-2022)“…Background PPMS (primary progressive multiple sclerosis) patients represent less than 10% of MS patients in Argentina, men and women were similarly affected…”
Get full text
Journal Article -
11
Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?
Published in Multiple sclerosis and related disorders (01-02-2022)“…•Data in cohort MS studies is seldom disaggregated by sex and males are poorly considered.•Results in MS studies may be markedly biased by the female…”
Get full text
Journal Article -
12
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America
Published in Multiple sclerosis and related disorders (01-06-2021)“…•RELACOEM is the first study conducted in LATAM evaluating risk of COVID-19 in patients with MS and NMOSD•We found an increased proportion of hospitalizations…”
Get full text
Journal Article -
13
Osteotomy as a treatment option in dysplasia epiphyseal hemimelica of the distal radius: a case report
Published in Journal of pediatric orthopaedics. B (01-07-2018)“…Dysplasia epiphysialis hemimelica (DEH), also known as Trevor disease, is a very rare disease characterized by an overgrowth of the osteocartilaginous…”
Get full text
Journal Article